Combinatorial Effect of Doxorubicin Entrapped in Alginate-Chitosan Hybrid Polymer and Cerium Oxide Nanocomposites on Skin Cancer Management in Mice.

Conventional chemotherapeutic drugs are used for cancer management, but recently nanoparticles have also been shown to contribute towards controlling cancer cell proliferation. In the present study, we focussed on analyzing the combinatorial effect of Cerium oxide (CeO) nanoparticles and Doxorubicin (Dox) on melanoma cancer cells in vitro and in vivo. We entrapped CeO, Dox, and CeO+Dox in a hybrid polymer matrix of alginate and chitosan (Alg-Cs) and used them in both in vitro and in vivo studies to compare their anticancer effect. Scratch assay using A549 lung cancer cells showed delayed wound healing when exposed to a low and high dose of CeO +Dox, compared to individual components. In order to determine a safe dose of the nanoformulations, zebrafish embryos were used. Further, in vivo, testing was done on Swiss albino female mice where the melanoma was induced by applying Benzopyrene followed by UV irradiation. The animals were treated with CeO, Dox, and CeO+ Dox that were entrapped in Alg-Cs for further 21 days. From both in vivo and in vitro results, we concluded that CeO and Dox in combination had superior therapeutic efficiency in cancer cells and animals than the nude drugs.